Emre Yekedüz

602 total citations
63 papers, 296 citations indexed

About

Emre Yekedüz is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Emre Yekedüz has authored 63 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Emre Yekedüz's work include Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Cancer Genomics and Diagnostics (11 papers). Emre Yekedüz is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Cancer Genomics and Diagnostics (11 papers). Emre Yekedüz collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Emre Yekedüz's co-authors include Yüksel Ürün, Güngör Utkan, Güngör Utkan, Hakan Akbulut, Mustafa Erman, Ömer Dızdar, Deniz Can Güven, Mehmet Alı Nahıt Şendur, Saadettin Kılıçkap and Toni K. Choueiri and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and International Journal of Cancer.

In The Last Decade

Emre Yekedüz

43 papers receiving 294 citations

Peers

Emre Yekedüz
Ghulam Haider Pakistan
Ruby Gupta United States
Megan Eguchi United States
Nandini Menon India
Aaron J. Feinstein United States
Maxime Frélaut France
Richa Chauhan India
Perrine Vuagnat France
Sandip Ganguly India
Savitri C. Ritoe Netherlands
Ghulam Haider Pakistan
Emre Yekedüz
Citations per year, relative to Emre Yekedüz Emre Yekedüz (= 1×) peers Ghulam Haider

Countries citing papers authored by Emre Yekedüz

Since Specialization
Citations

This map shows the geographic impact of Emre Yekedüz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emre Yekedüz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emre Yekedüz more than expected).

Fields of papers citing papers by Emre Yekedüz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emre Yekedüz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emre Yekedüz. The network helps show where Emre Yekedüz may publish in the future.

Co-authorship network of co-authors of Emre Yekedüz

This figure shows the co-authorship network connecting the top 25 collaborators of Emre Yekedüz. A scholar is included among the top collaborators of Emre Yekedüz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emre Yekedüz. Emre Yekedüz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kuzu, Omer F., Sung Hoon Sim, Deniz Tural, et al.. (2025). Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma. BMC Cancer. 25(1). 1220–1220.
3.
Saad, Eddy, Renée Maria Saliby, Emre Yekedüz, et al.. (2025). Circulating kidney injury molecule-1 (KIM-1) in association with kidney injury biomarkers and outcomes in metastatic renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 582–582. 1 indexed citations
4.
Yekedüz, Emre, et al.. (2025). Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors. Clinical & Translational Oncology. 27(7). 3175–3182. 2 indexed citations
5.
6.
Yekedüz, Emre, et al.. (2024). Thromboembolic risk in prostate cancer patients treated with PARP inhibitors: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 198. 104376–104376. 1 indexed citations
7.
Yekedüz, Emre, David A. Braun, Chris Labaki, et al.. (2024). 24 Applying genomic analysis to refine unclassified renal cell carcinoma. The Oncologist. 29(Supplement_1). S20–S20. 1 indexed citations
8.
Saliby, Renée Maria, Eddy Saad, Emre Yekedüz, et al.. (2024). 59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The Oncologist. 29(Supplement_1). S1–S1.
9.
Yekedüz, Emre, et al.. (2024). Meta-analysis of platinum chemotherapy combinations with immunotherapy in metastatic urothelial carcinoma. The Oncologist. 29(11). 999–1002.
10.
Zarif, Talal El, Paul Stockhammer, Emre Yekedüz, et al.. (2024). ERBB2 mutations and association with molecular phenotype in urothelial carcinoma.. Journal of Clinical Oncology. 42(16_suppl). 4590–4590.
11.
12.
Yekedüz, Emre, et al.. (2022). Vortex keratopathy associated with ribociclib. Journal of Oncology Pharmacy Practice. 29(1). 230–232. 5 indexed citations
13.
Yekedüz, Emre, Deniz Tural, Özlem Erçelep, et al.. (2022). The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors. Scientific Reports. 12(1). 16559–16559. 10 indexed citations
14.
Güven, Deniz Can, Emre Yekedüz, Enes Erul, et al.. (2022). The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study. Journal of Cancer Research and Clinical Oncology. 149(7). 3599–3606. 5 indexed citations
15.
Yekedüz, Emre, Hasan Çağrı Yıldırım, Feyyaz Özdemir, et al.. (2022). Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. European Journal of Clinical Pharmacology. 78(12). 1973–1979. 2 indexed citations
16.
Yekedüz, Emre, et al.. (2021). mRNA-based COVID-19 Vaccines Appear to not Increase Immune Events in Cancer Patients Receiving Immune Checkpoint Inhibitors. Future Virology. 16(9). 583–585. 2 indexed citations
17.
Güven, Deniz Can, Ramazan Acar, Emre Yekedüz, et al.. (2021). The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study. Current Problems in Cancer. 45(6). 100760–100760. 16 indexed citations
18.
Yekedüz, Emre, İlker Özgür, Güngör Utkan, et al.. (2021). Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study. Journal of Gastrointestinal Cancer. 53(4). 870–879. 9 indexed citations
19.
Alkan, Ali, Emre Yekedüz, & Filiz Çay Şenler. (2020). Ölmekte Olan Kanser Hastalarında Semptom Kontrolü ve Yaşam Sonu Desteği. 13(1). 75–82. 1 indexed citations
20.
Güven, Deniz Can, Ömer Dızdar, Abdullah C. Akman, et al.. (2019). Evaluation of cancer risk in patients with periodontal diseases. TURKISH JOURNAL OF MEDICAL SCIENCES. 49(3). 826–831. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ghulam Haider Breakdown of academic impact, for papers by Ruby Gupta Breakdown of academic impact, for papers by Megan Eguchi Breakdown of academic impact, for papers by Nandini Menon Breakdown of academic impact, for papers by Aaron J. Feinstein Breakdown of academic impact, for papers by Maxime Frélaut Breakdown of academic impact, for papers by Richa Chauhan Breakdown of academic impact, for papers by Perrine Vuagnat Breakdown of academic impact, for papers by Sandip Ganguly Breakdown of academic impact, for papers by Savitri C. Ritoe
Rankless by CCL
2026